Particle.news

Download on the App Store

HHS Urges End to Puberty Blockers, Cross-Sex Hormones and Surgeries for Transgender Minors

A federal HHS review found insufficient evidence supporting gender-affirming treatments for minors

Transgender people have been a major focus of the second Trump administration.
FILE - People gather in support of transgender youth during a rally at the Utah State Capitol Tuesday, Jan. 24, 2023, in Salt Lake City. (AP Photo/Rick Bowmer, File)

Overview

  • HHS Secretary Robert F. Kennedy Jr. directed healthcare providers, risk managers and state medical boards to update treatment protocols after a department review found very weak evidence for puberty blockers, cross-sex hormones and surgeries in minors with gender dysphoria.
  • The guidance tells providers to disregard the World Professional Association for Transgender Health’s Standards of Care, labeling them unscientific and potentially harmful to children.
  • The American Medical Association and American Academy of Pediatrics have rejected the new guidelines and affirmed that gender-affirming care can provide essential medical benefits and improve well-being for transgender youth.
  • The Centers for Medicare and Medicaid Services announced an oversight initiative to review hospitals performing gender transition surgeries on minors over concerns of lifelong harm and scant evidence.
  • Senator Bill Cassidy praised the move, warning that irreversible gender transition procedures for children contradict scientific data and calling for stricter accountability in pediatric care.